Sign In
Buy MNTA
$52.48
+0 (+0%)
At Close: May 27, 2022
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Shares Purchased by Louisiana State Employees Retirement System
06:20pm, Thursday, 16'th Jul 2020
Louisiana State Employees Retirement System grew its stake in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) by 17.2% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned
Charting a bull-trend whipsaw, S&P 500 nails next resistance
04:35pm, Tuesday, 14'th Jul 2020
Technically speaking, the U.S. benchmarks have registered a mid-July market whipsaw, writes Michael Ashbaugh, pressured at least briefly amid the month’s...
Did Hedge Funds Make The Right Call On Momenta Pharmaceuticals, Inc. (MNTA) ?
09:04pm, Monday, 13'th Jul 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Annexon Initiates $100 Million IPO Effort
11:00am, Saturday, 11'th Jul 2020
Annexon aims to raise $100 million in an IPO, although the final figure may differ. The firm is advancing treatments for various autoimmune and neurodegenerative disorders.
Charting a bullish July start, Nasdaq extends break to record territory
04:20pm, Tuesday, 07'th Jul 2020
Technically speaking, the major U.S. benchmarks are off to a constructive July start despite persistently uneven price action, writes Michael Ashbaugh.
Top Ranked Momentum Stocks to Buy for July 6th
11:32am, Monday, 06'th Jul 2020
Top Ranked Momentum Stocks to Buy for July 6th
Aimmune Appoints Narinder Singh as Executive Vice President of Technical Operations
12:00am, Monday, 06'th Jul 2020
Aimmune Appoints Narinder Singh as Executive Vice President of Technical Operations
30,065 Shares in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Bought by FDx Advisors Inc.
07:58am, Sunday, 05'th Jul 2020
FDx Advisors Inc. acquired a new position in shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) during the 1st quarter, according to the company in its most recent disclosure with the Securities an
Charting market cross currents, S&P 500 maintains 200-day average
04:47pm, Tuesday, 30'th Jun 2020
Technically speaking, the major U.S. benchmarks are poised to conclude June against an increasingly uneven, but still generally bullish, bigger-picture...
The Zacks Analyst Blog Highlights: Domo, ViewRay, Commercial Metals, Clearwater Paper and Momenta Pharmaceuticals
02:45pm, Monday, 29'th Jun 2020
The Zacks Analyst Blog Highlights: Domo, ViewRay, Commercial Metals, Clearwater Paper and Momenta Pharmaceuticals
Brokerages Set Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) PT at $40.43
08:28am, Monday, 29'th Jun 2020
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has been given an average recommendation of “Buy” by the eleven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two anal
Momenta (MNTA) Upgraded to Strong Buy: What Does It Mean for the Stock?
04:00pm, Friday, 26'th Jun 2020
Momenta (MNTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
5 Top Momentum Stocks of June Amid Resurgence of Coronavirus
11:30am, Friday, 26'th Jun 2020
Despite market's roller-coaster ride, a handful of momentum stocks with a favorable Zacks Rank have provided double-digit returns so far in June.
Stifel Nicolaus Reaffirms “Buy” Rating for Momenta Pharmaceuticals (NASDAQ:MNTA)
03:10am, Thursday, 25'th Jun 2020
Momenta Pharmaceuticals (NASDAQ:MNTA)‘s stock had its “buy” rating reaffirmed by Stifel Nicolaus in a report issued on Wednesday, TipRanks reports. Several other analysts also recently commented
Stifel Nicolaus Believes Momenta Pharma (NASDAQ: MNTA) Won't Stop Here - Markets
09:09pm, Wednesday, 24'th Jun 2020
Stifel Nicolaus analyst Derek Archila reiterated a Buy rating on Momenta Pharma (MNTA – Research Report) today. The company’s shares
